Literature DB >> 21989803

A modified adjusting delay task to assess impulsive choice between isocaloric reinforcers in non-deprived male rats: effects of 5-HT₂A/C and 5-HT₁A receptor agonists.

Angelo Blasio1, Aditi R Narayan, Barbara J Kaminski, Luca Steardo, Valentina Sabino, Pietro Cottone.   

Abstract

RATIONALE: Existing animal models of impulsivity frequently use food restriction to increase subjects' motivation. In addition, behavioral tasks that assess impulsive choice typically involve the use of reinforcers with dissimilar caloric content. These factors represent energy-homeostasis limitations, which may confound the interpretation of results and limit the applicability of these models.
OBJECTIVES: This study was aimed at validating face and convergent validities of a modified adjusting delay task, which assesses impulsive choice between isocaloric reinforcers in ad libitum fed rats.
METHODS: Male Wistar rats (n = 18) were used to assess the preferredness and reinforcing efficacy of a "supersaccharin" solution (1.5% glucose/0.4% saccharin) over a 1.5% glucose solution. A separate group of rats (n = 24) was trained in a modified adjusting delay task, which involved repeated choice between the glucose solution delivered immediately and the supersaccharin solution delivered after a variable delay. To pharmacologically validate the task, the effects of the 5-HT(2A/C) receptor agonist (±)-1-(2,5-dimethoxy-4-iodophenyl)-2-aminopropane [(±)-DOI] and the 5-HT(1A) receptor agonist (±)-8-hydroxy-2-(dipropylamino)tetralin hydrobromide [(±)-8-OH-DPAT] on impulsive choice were then evaluated.
RESULTS: Supersaccharin was highly reinforcing and uniformly preferred over the glucose solution by all subjects. Rats quickly learned the task, and impulsivity was a very stable and consistent trait. DOI and 8-OH-DPAT significantly and dose dependently increased impulsive choice in this modified adjusting delay task.
CONCLUSIONS: We validated a rodent task of impulsive choice, which eliminates typical energy-homeostasis limitations and, therefore, opens new avenues in the study of impulsivity in preclinical feeding and obesity research.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21989803      PMCID: PMC3936353          DOI: 10.1007/s00213-011-2517-8

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


  73 in total

Review 1.  Endocannabinoid control of food intake and energy balance.

Authors:  Vincenzo Di Marzo; Isabel Matias
Journal:  Nat Neurosci       Date:  2005-05       Impact factor: 24.884

Review 2.  Personality and eating disorders: a decade in review.

Authors:  Stephanie E Cassin; Kristin M von Ranson
Journal:  Clin Psychol Rev       Date:  2005-11

3.  Increased mRNA levels of tyrosine hydroxylase and dopamine transporter in the VTA of male rats after chronic food restriction.

Authors:  Jonas Lindblom; Andreas Johansson; Andreas Holmgren; Elisabeth Grandin; Carina Nedergård; Robert Fredriksson; Helgi B Schiöth
Journal:  Eur J Neurosci       Date:  2006-01       Impact factor: 3.386

4.  To do or not to do? The complexities of addiction, motivation, self-control, and impulsivity.

Authors:  Marc N Potenza
Journal:  Am J Psychiatry       Date:  2007-01       Impact factor: 18.112

5.  Synthesis, protein levels, activity, and phosphorylation state of tyrosine hydroxylase in mesoaccumbens and nigrostriatal dopamine pathways of chronically food-restricted rats.

Authors:  Yan Pan; Yemiliya Berman; Sandra Haberny; Emanuel Meller; Kenneth D Carr
Journal:  Brain Res       Date:  2006-09-28       Impact factor: 3.252

6.  Dissociation between opioid and CRF1 antagonist sensitive drinking in Sardinian alcohol-preferring rats.

Authors:  Valentina Sabino; Pietro Cottone; George F Koob; Luca Steardo; Mei J Lee; Kenner C Rice; Eric P Zorrilla
Journal:  Psychopharmacology (Berl)       Date:  2006-10-18       Impact factor: 4.530

7.  Interactions between serotonin and dopamine in the control of impulsive choice in rats: therapeutic implications for impulse control disorders.

Authors:  Catharine A Winstanley; David E H Theobald; Jeffrey W Dalley; Trevor W Robbins
Journal:  Neuropsychopharmacology       Date:  2005-04       Impact factor: 7.853

8.  FG 7142 specifically reduces meal size and the rate and regularity of sustained feeding in female rats: evidence that benzodiazepine inverse agonists reduce food palatability.

Authors:  Pietro Cottone; Valentina Sabino; Luca Steardo; Eric P Zorrilla
Journal:  Neuropsychopharmacology       Date:  2006-11-01       Impact factor: 7.853

Review 9.  Behavioral models of impulsivity in relation to ADHD: translation between clinical and preclinical studies.

Authors:  Catharine A Winstanley; Dawn M Eagle; Trevor W Robbins
Journal:  Clin Psychol Rev       Date:  2006-02-28

Review 10.  The neuropsychiatry of impulsivity.

Authors:  Samuel R Chamberlain; Barbara J Sahakian
Journal:  Curr Opin Psychiatry       Date:  2007-05       Impact factor: 4.741

View more
  16 in total

1.  Differential effects of cannabinoid CB1 inverse agonists and antagonists on impulsivity in male Sprague Dawley rats: identification of a possibly clinically relevant vulnerability involving the serotonin 5HT1A receptor.

Authors:  Peter J McLaughlin; Julia E Jagielo-Miller; Emily S Plyler; Kerry K Schutte; V Kiran Vemuri; Alexandros Makriyannis
Journal:  Psychopharmacology (Berl)       Date:  2017-02-01       Impact factor: 4.530

2.  5-HT3 antagonists decrease discounting rate without affecting sensitivity to reward magnitude in the delay discounting task in mice.

Authors:  Marina Mori; Iku Tsutsui-Kimura; Masaru Mimura; Kenji F Tanaka
Journal:  Psychopharmacology (Berl)       Date:  2018-06-28       Impact factor: 4.530

Review 3.  Dissecting drug effects in preclinical models of impulsive choice: emphasis on glutamatergic compounds.

Authors:  Justin R Yates
Journal:  Psychopharmacology (Berl)       Date:  2018-01-06       Impact factor: 4.530

4.  Role of medial prefrontal and orbitofrontal monoamine transporters and receptors in performance in an adjusting delay discounting procedure.

Authors:  Justin R Yates; Jennifer L Perry; Andrew C Meyer; Cassandra D Gipson; Richard Charnigo; Michael T Bardo
Journal:  Brain Res       Date:  2014-06-10       Impact factor: 3.252

5.  Antagonism of sigma-1 receptors blocks compulsive-like eating.

Authors:  Pietro Cottone; Xiaofan Wang; Jin Won Park; Marta Valenza; Angelo Blasio; Jina Kwak; Malliga R Iyer; Luca Steardo; Kenner C Rice; Teruo Hayashi; Valentina Sabino
Journal:  Neuropsychopharmacology       Date:  2012-06-20       Impact factor: 7.853

6.  Impulsive choice does not predict binge-like eating in rats.

Authors:  Catherine F Moore; Angelo Blasio; Valentina Sabino; Pietro Cottone
Journal:  Behav Pharmacol       Date:  2018-12       Impact factor: 2.293

7.  Effects of N-methyl-D-aspartate receptor ligands on sensitivity to reinforcer magnitude and delayed reinforcement in a delay-discounting procedure.

Authors:  Justin R Yates; Benjamin T Gunkel; Katherine K Rogers; Mallory N Hughes; Nicholas A Prior
Journal:  Psychopharmacology (Berl)       Date:  2016-11-11       Impact factor: 4.530

8.  Frontal Traumatic Brain Injury Increases Impulsive Decision Making in Rats: A Potential Role for the Inflammatory Cytokine Interleukin-12.

Authors:  Cole Vonder Haar; Kris M Martens; Lara-Kirstie Riparip; Susanna Rosi; Cheryl L Wellington; Catharine A Winstanley
Journal:  J Neurotrauma       Date:  2017-05-24       Impact factor: 5.269

9.  Opioid system in the medial prefrontal cortex mediates binge-like eating.

Authors:  Angelo Blasio; Luca Steardo; Valentina Sabino; Pietro Cottone
Journal:  Addict Biol       Date:  2013-01-24       Impact factor: 4.280

10.  The uncompetitive NMDA receptor antagonists ketamine and memantine preferentially increase the choice for a small, immediate reward in low-impulsive rats.

Authors:  Pietro Cottone; Attilio Iemolo; Aditi R Narayan; Jina Kwak; Duncan Momaney; Valentina Sabino
Journal:  Psychopharmacology (Berl)       Date:  2012-10-27       Impact factor: 4.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.